An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditionsWinnie Chua, Larissa Fabritz, Stef Zeemering et al.|Scientific Reports|2023Cited by 28
Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule studyLarissa Fabritz, Paulus Kirchhof, Stéphane Hatem et al.|European Heart Journal|2024Cited by 27
Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule studyLarissa Fabritz, Paulus Kirchhof, Anna Suling et al.|Cardiovascular Research|2024Cited by 20